March 11, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and ...

Glencar has been selected as the main contractor for Trehus, a sustainable timber-framed office building in Maidenhead, Thames Valley, England. The 79,200ft² commercial development structure aims ...

Deep-pocketed investors have adopted a bullish approach towards Biogen BIIB, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Investors with a lot of money to spend have taken a bullish stance on Biogen BIIB. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

High-rolling investors have positioned themselves bullish on Biogen (NASDAQ:BIIB), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...

Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...

Biogen Inc. (BIIB), based in Cambridge, Massachusetts, is a leading biotechnology company focused on developing and delivering innovative therapies for neurological and neurodegenerative diseases ...

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...

Glencar has been selected as the main contractor for Trehus, a sustainable timber-framed office building in Maidenhead, Thames Valley, England. The 79,200ft² commercial development structure aims for ...

Sports Mole previews Tuesday's National League clash between Maidenhead United and Aldershot Town, including predictions, team news and possible lineups. Alan Devonshire's Maidenhead have been in ...

Pradeep Ranganathan's new film 'Dragon' premiered on February 21, 2025, earning Rs 6 crore on its first day. The romantic comedy-drama saw impressive occupancy rates, especially during night shows.